$3.55
-0.29-7.55%
近くで: Nov 20, 4:00 PM EST
$3.56
0.010.28%
時間外: 7:58 PM EST
The average analyst price target for Prime Medicine is $9.60, 169.7% above the current price. Of 13 analysts, 11 rate it Buy and 2 Hold. Targets range from $4.25 to $18. The latest change came on Aug 19, 2026, when BMO Capital initiated coverage of Prime Medicine with an Outperform rating and a $9 price target.
Price Target Range — 13 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
